Haim Leibovitzh

7PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 16, 2026
Comparison of Tacrolimus and Infliximab for Acute Severe Ulcerative Colitis in Hospitalized Adults: A Retrospective Study.

|Apr 02, 2026
Phage-Display Immunoprecipitation Sequencing Reveals Distinct Antibody Signatures Against Bacterial Flagellins Associated With Treatment Response in Crohn's Disease.

Haim Leibovitzh, David Krongauz, Yishay Schlesinger

|Oct 10, 2025
Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic-Experienced Patients With Ulcerative Colitis: A Retrospective Study.

Neta Sror, Haim Leibovitzh, Ayal Hirsch

|Sep 05, 2025
Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.

Mingyue Xue, Sun-Ho Lee, Jingchen Shao

|Jul 09, 2024
Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile.

Haim Leibovitzh, Shadi Nayeri, Krzysztof Borowski

|May 09, 2024
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone.

Haim Leibovitzh, Chen Sarbagili Shabat, Ayal Hirsch

Pageof 2

Frequent Collaborators

2 joint publications

Sun-Ho Lee

2 joint publications

Kenneth Croitoru

2 joint publications

Neta Sror

1 joint publications

Azucena Salas